Get started
Cel-Sci CorporationCC

Cel-Sci Corporation

2.29USDR
−0.03−1.29%
Last update at Jun 18, 23:53 GMT
USD
No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

CVM chart


Full chart

CVM upcoming earnings


Next report date
≈
August 18
Report period
Q3 2025
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪11.76 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−12.26 USD
Net income (FY)
‪−26.92 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪5.14 M‬
Beta (1Y)
1.69

About Cel-Sci Corporation


Sector
Health Technology
Industry
Biotechnology
CEO
Geert R. Kersten
Website
cel-sci.com
Headquarters
Vienna
Founded
1983
FIGI
BBG000H5G6L5
CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Financials


Performance
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪‪−8.00 M‬‬
‪‪−6.00 M‬‬
‪‪−4.00 M‬‬
‪‪−2.00 M‬‬
‪0.00‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−6.80 M‬‬
‪‪−5.10 M‬‬
‪‪−3.40 M‬‬
‪‪−1.70 M‬‬
‪0.00‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−6.80 M‬‬
‪‪−5.10 M‬‬
‪‪−3.40 M‬‬
‪‪−1.70 M‬‬
‪0.00‬
Debt level and coverage
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪‪−5.00 M‬‬
‪0.00‬
‪‪5.00 M‬‬
‪‪10.00 M‬‬
‪‪15.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:Aug 18, 2025
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
‪−4.40‬
‪−3.30‬
‪−2.20‬
‪−1.10‬
‪0.00‬
Actual
Estimate

CVM news



No news here

Looks like there's nothing to report right now

Reload

Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CVM is 2.29 USD — it has decreased by −1.29% in the past 24 hours. Watch Cel-Sci Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Cel-Sci Corporation stocks are traded under the ticker CVM.
CVM stock has fallen by −7.08% compared to the previous week, the month change is a −67.40% fall, over the last year Cel-Sci Corporation has showed a −94.17% decrease.
We've gathered analysts' opinions on Cel-Sci Corporation future price: according to them, CVM price has a max estimate of 300.00 USD and a min estimate of 300.00 USD. Watch CVM chart and read a more detailed Cel-Sci Corporation stock forecast: see what analysts think of Cel-Sci Corporation and suggest that you do with its stocks.
CVM reached its all-time high on May 23, 1986 with the price of 642,187.50 USD, and its all-time low was 1.98 USD and was reached on Jun 2, 2025. View more price dynamics on CVM chart.
See other stocks reaching their highest and lowest prices.
CVM stock is 20.61% volatile and has beta coefficient of 1.69. Track Cel-Sci Corporation stock price on the chart and check out the list of the most volatile stocks — is Cel-Sci Corporation there?
Today Cel-Sci Corporation has the market capitalization of ‪11.76 M‬, it has decreased by −6.45% over the last week.
Yes, you can track Cel-Sci Corporation financials in yearly and quarterly reports right on TradingView.
Cel-Sci Corporation is going to release the next earnings report on Aug 18, 2025. Keep track of upcoming events with our Earnings Calendar.
CVM net income for the last quarter is ‪−6.57 M‬ USD, while the quarter before that showed ‪−7.07 M‬ USD of net income which accounts for 7.08% change. Track more Cel-Sci Corporation financial stats to get the full picture.
No, CVM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CVM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cel-Sci Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cel-Sci Corporation technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cel-Sci Corporation stock shows the sell signal. See more of Cel-Sci Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.